Trxade Health Inc (NASDAQ: MEDS) stock suffered a major decline of -11.2% on 12/26/24. The shares closed at $6.65. However, trading volume in this decline was below average at 73% of normal. The stock has performed in line with the market over the last nine months and has declined -16.9% during the last week.
Current PriceTarget Research Rating
Trxade Health has a current Value Trend Rating of F (Lowest Rating). With this rating, PTR’s two proprietary measures of a stock’s current attractiveness are providing complementary signals. Trxade Health has a slightly negative Power Rating of 38 and a very low Appreciation Score of 2, with the Lowest Value Trend Rating the result.
Rating Review
In light of this highly negative price change we are reviewing our current Overall Rating of F. This review will be completed in the next several days.
Be the first to comment